STSS
Sharps Technology, Inc.Healthcare·Medical - Instruments & Supplies
$1.84
$78M market cap
Revenue
$0.1M
Free Cash Flow
$-4.3M
Rev Growth
+0.0%
FCF Margin
-4693.9%
P/FCF
--
EV/FCF
--
Fwd EV/EBITDA
--
Fair Value
--
Upside
--
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
2-Year Price History
$1.81-99.9%
Quarterly Financials & Projections
Quarterly Waterfall ($ M)
| Period | Rev | EBITDA | OpIn | NI | OCF | FCF | CapEx | Cash | Debt | Shares | ROIC | IntCov | EV/EBITDA | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Act | 2026-Q1 | 0.2 | -4.5 | -4.6 | -86.2 | -2.7 | -2.7 | -0.0 | 12.3 | 0.0 | 72.6 | -- | -- | -- |
| Act | 2025-Q4 | -0.1 | -154.2 | 102.4 | -182.7 | -5.0 | -1.6 | -3.4 | 10.4 | 3.1 | 25.3 | 460.2% | -1279.5x | -- |
Valuation & Metrics
Market Stats
Price$1.84
Market Cap$78M
Enterprise Value$66M
P/S Ratio859.9x
P/FCF--
EV/FCF--
FCF Margin (TTM)-4693.9%
FCF Yield-5.5%
Dividend Yield (TTM)--
Annual Dilution0.0%
CurrencyUSD
TTM Financial Snapshot
Revenue$0.1M
Net Income$-268.9M
Free Cash Flow$-4.3M
Revenue Growth (YoY)+0.0%
EBITDA Margin-175347.9%
Net Margin-296939.1%
FCF Margin-4693.9%
CapEx % of Revenue3756.6%
SBC % of Revenue2762.6%
ROIC460.2%
WC Change % Rev1649.2%
Interest Coverage-1317.2x
Forward Outlook & Risk
Short Interest
Short % of Float--
Short Shares0.6M
Days to Cover1.9
Change (vs Prior)-4.8%
Need at least 2 settlement dates for chart
Employees
Headcount55
Revenue / Employee$1,646
Gross Profit / Employee$32,337
Cash Runway
34.8months
WATCH
Institutional Ownership
Headline & net flow
NEUTRAL
Net flow · —still filing
No float data — flow unavailable.
Ownership composition
Active
16.8%(+16.7% YoY)
21 filers
hedge / family / endowment
Retail funds
—
Fidelity, Schwab, 401(k)
Passive
4.1%(+4.1% YoY)
7 filers
Vanguard, iShares, SPDR
Market makers
0.1%(+0.1% YoY)
2 filers
Citadel, Susquehanna
Insiders
—
Form 4 — latest per insider
ActiveRetail fundsPassiveMarket makersRetail direct
Top holders
| Fund | $ value | Cost basis | Δ QoQ | Δ YoY | α life | Fund AUM |
|---|---|---|---|---|---|---|
| Saba Capital Management, L.P. | $2.5M | $1.73 | +$2.2M | +$2.5M | -4.4% | $3.09B |
| VANGUARD CAPITAL MANAGEMENT LLCPassive | $2.0M | $1.68 | +$2.0M | +$2.0M | — | $4.04T |
| ParaFi Capital LP | $1.9M | $1.68 | +$1.9M | +$1.9M | -42.2% | $294M |
| Pantera Capital Partners LP | $1.9M | $6.52 | +$0 | +$1.9M | -24.9% | $158M |
| Arrington Capital Management, LLC | $1.8M | $1.99 | +$202K | +$1.8M | -11.5% | $88.1M |
| SCOGGIN MANAGEMENT LP | $1.7M | $2.03 | −$252K | +$1.7M | +0.1% | $254M |
| CITADEL ADVISORS LLC | $1.5M | $1.68 | +$1.5M | +$1.5M | -0.4% | $138.22B |
| Feynman Point Asset Management LLC | $680K | $2.03 | −$247K | +$680K | +12.5% | $29.1M |
| GEODE CAPITAL MANAGEMENT, LLCPassive | $574K | $2.12 | +$102K | +$574K | +2.3% | $1.61T |
| UBS Group AG | $459K | $1.72 | +$446K | +$459K | -0.3% | $562.11B |
| WOLVERINE ASSET MANAGEMENT LLC | $292K | $1.68 | +$292K | +$292K | +1.9% | $2.32B |
| VANGUARD FIDUCIARY TRUST COPassive | $276K | $1.68 | +$276K | +$276K | — | $395.83B |
| CANTOR FITZGERALD, L. P. | $258K | $1.68 | +$258K | +$258K | -3.1% | $2.75B |
| STATE STREET CORPPassive | $200K | $1.68 | +$200K | +$200K | -0.2% | $2.89T |
| BlackRock, Inc.Passive | $159K | $2.03 | +$0 | +$159K | -0.2% | $5.69T |
| Spears Abacus Advisors LLC | $141K | $1.68 | +$141K | +$141K | +1.3% | $5.06B |
| Schonfeld Strategic Advisors LLC | $114K | $6.52 | −$2.5M | +$114K | +1.3% | $12.20B |
| NORTHERN TRUST CORPPassive | $102K | $2.03 | +$0 | +$102K | -0.2% | $755.34B |
| Quadrature Capital Ltd | $86K | $1.68 | +$86K | +$86K | +1.3% | $8.40B |
| SUSQUEHANNA INTERNATIONAL GROUP, LLPMM | $68K | $1.68 | +$68K | +$68K | -0.6% | $77.14B |
Cost basis is a volume-weighted estimate from accumulation periods within our 13F history; holders who built their position before our window started will show a stale basis. % above the cost basis is the unrealized gain at the current price.
Trading behavior
Smart-money alpha (lifetime, %/qtr)BEARISH
Holders
-11.42%
avg per quarter
Holders (ex-self)
-11.38%
excl. this stock
Buyers (this Q)
-13.52%
19 buyers · $0.01B in
Sellers (this Q)
+2.28%
5 sellers · $0.00B out
alpha coverage: 87% of $ has a lifetime-alpha record
Holder behavior on this stocksource: stock
On big dips (−10%+)
-11.5%
how holders react when this stock falls
On quiet Qs
-11.4%
−10% to +10% baseline
On rallies (+10%+)
+9.8%
how they react when this stock rises
Holders' portfolio flow this Q
-2.4%
outflows — trims may be forced
Sellers' portfolio flow this Q
-33.1%
Sellers shed AUM broadly — partly forced.
▸ Compare to holder-profile behavior (across all their stocks)
Holder dip (any stock)
-2.3%
Holder mid (any stock)
-11.4%
Holder rally (any stock)
-11.2%
Biggest decreases this quarter
Schonfeld Strategic Advisors LLC−$2.5Mα+1.3HBK INVESTMENTS L Pexited−$1.4MCoinFund Management LLCexited−$437KSCOGGIN MANAGEMENT LP−$252Kα+0.1Feynman Point Asset Management LLC−$247Kα+12.5T3 Companies, LLCexited−$68KAristides Capital LLCexited−$25KEngineers Gate Manager LPexited−$23KBANK OF AMERICA CORP /DE/exited−$0
New buyers this quarter
VANGUARD CAPITAL MANAGEMENT LLC+$0.00BParaFi Capital LP+$0.00Bα-42.2CITADEL ADVISORS LLC+$0.00Bα-0.4WOLVERINE ASSET MANAGEMENT LLC+$0.00Bα+1.9VANGUARD FIDUCIARY TRUST CO+$0.00BCANTOR FITZGERALD, L. P.+$0.00Bα-3.1STATE STREET CORP+$0.00Bα-0.2Spears Abacus Advisors LLC+$0.00Bα+1.3Quadrature Capital Ltd+$0.00Bα+1.3SUSQUEHANNA INTERNATIONAL GROUP, LLP+$0.00Bα-0.6
Top-5 holders · 60.2%
Saba Capital Management, L.P.--
VANGUARD CAPITAL MANAGEMENT LLC--
ParaFi Capital LP--
Pantera Capital Partners LP--
Arrington Capital Management, LLC--
Top Holders Over Time
5-year share-count history (top 10 holders by peak, incl. exited) + price
hover the chart for per-quarter detailprice (right axis)
Schonfeld Strategic Advisors LLC68KPantera Capital Partners LP1.1MSaba Capital Management, L.P.1.5MSCOGGIN MANAGEMENT LP1.0MParaFi Capital LP1.1MArrington Capital Management, LLC1.0MCITADEL ADVISORS LLC874KHBK INVESTMENTS L P—Feynman Point Asset Management LLC405KOMERS ADMINISTRATION Corp—
Analyst Coverage
Analyst Coverage
Analyst Ratings
1
Buy: 1Consensus: Buy
Corporate
Insider Trading (last 12mo)
Open-market only (Form 4 P-Purchase + S-Sale). Excludes grants, option exercises, tax withholding, gifts.
Officers & directors
Buys ($, 12mo)
$5.58M
9 txns · 7 insiders · 840,005 sh
Sells ($, 12mo)
$335K
1 txn · 1 insider · 20,000 sh
Major holders (≥10% beneficial owners)
Buys ($, 12mo)
$0
0 txns · 0 insiders · 0 sh
Sells ($, 12mo)
$1.44M
6 txns · 2 insiders · 721,660 sh
Recent transactions
| Date | Side | Insider | Title | Shares | Price | Dollars | Owned $ |
|---|---|---|---|---|---|---|---|
| 2026-01-16 | SELL | Saba Capital Management, L.P. | 10 percent owner | 12,182 | $2.37 | $29K | $3.58M |
| 2026-01-15 | SELL | Saba Capital Management, L.P. | 10 percent owner | 25,000 | $2.30 | $58K | $3.51M |
| 2026-01-14 | SELL | Saba Capital Management, L.P. | 10 percent owner | 77,688 | $2.25 | $175K | $3.49M |
| 2026-01-13 | SELL | Saba Capital Management, L.P. | 10 percent owner | 29,777 | $2.19 | $65K | $3.56M |
| 2026-01-12 | SELL | FalconX Holdings Ltd | 10 percent owner | 47,281 | $1.97 | $93K | $0 |
| 2026-01-09 | SELL | FalconX Holdings Ltd | 10 percent owner | 529,732 | $1.93 | $1.02M | $91K |
| 2025-08-27 | SELL | Ruemler Timothy James | director | 20,000 | $16.74 | $335K | $338K |
| 2025-08-25 | BUY | Ruemler Timothy James | director | 40,000 | $11.36 | $454K | $457K |
| 2025-08-22 | BUY | Christiansen Soren Bo | director | 80,000 | $6.41 | $513K | $513K |
| 2025-08-22 | BUY | Crescenzo Andrew R. | director, officer: Chief Financial Officer | 40,000 | $6.41 | $256K | $256K |
| 2025-08-22 | BUY | DANNER PAUL K | director | 400,000 | $6.41 | $2.56M | $2.56M |
| 2025-08-22 | BUY | Hayes Robert Michael | director | 100,000 | $6.41 | $641K | $641K |
| 2025-08-22 | BUY | Monroe Jason L. | director | 80,000 | $6.41 | $513K | $513K |
| 2025-08-22 | BUY | Ruemler Timothy James | director | 80,000 | $6.41 | $513K | $513K |
| 2025-08-22 | BUY | Simpson Brenda Baird | director | 20,000 | $6.41 | $128K | $128K |
| 2025-07-15 | BUY | DANNER PAUL K | director | 5 | $20.00 | $100 | $100 |
Order Flow (FINRA, ~3w lag)
44.4%retail+6.5pp
10.5%dark-6.7pp
week of 2026-04-13
Off-exchange volume from FINRA. Retail = non-ATS (wholesaler PFOF + broker internalization). Dark = ATS (dark-pool crossing networks, institutional). Lit-exchange = remainder.
Filing Risk Analysis
Filing Risk Scores
Sharps Technology: A Medical Syringe Pivot Masking Massive Insider Enrichment and Hyper-Dilution
Overall Risk
10/10
Fraud
9/10
Dilution
10/10
Insolvency
4/10
Earnings Overstated
7/10
Hidden Liabilities
6/10
Legal
8/10
Audit Warnings
5/10
Hidden Upside
2/10
Contextually Acceptable
1/10